XML 177 R126.htm IDEA: XBRL DOCUMENT
v3.22.4

Earnings per Share (Narratives) (Details) | 12 Months Ended
--- | ---
Dec. 31, 2022
Notes to Consolidated Financial Statements [Abstract] |
Description of instruments with potential future dilutive effect not included in calculation of diluted earnings per share | As of December 31, 2022, the outstanding options in the amount of 7 million, representing 2.6 million shares, were included in the diluted weighted average number of ordinary shares calculation. As of December 31, 2021, all 12 million outstanding options were included. As of December 31, 2020, 27 million options, were not included since they did not have a diluting effect.

X
- References No definition available. + Details
Name: | icl_NotesToConsolidatedFinancialStatementsAbstract
Namespace Prefix: | icl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share because they are antidilutive for the period(s) presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2022-03-24 -Paragraph 70 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration